Home > National Drug Code (NDC) > Treatment Set TS350619

Treatment Set TS350619 - 49288-0940-3 - (Treatment Set TS350619)

Alphabetical Index


Drug Information of Treatment Set TS350619

Product NDC: 49288-0940
Proprietary Name: Treatment Set TS350619
Non Proprietary Name: Treatment Set TS350619
Active Ingredient(s): 304.04; 10000; .01    [BAU]/mL; [BAU]/mL; g/mL & nbsp;   Treatment Set TS350619
Administration Route(s): INTRADERMAL; SUBCUTANEOUS
Dosage Form(s): INJECTION, SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of Treatment Set TS350619

Product NDC: 49288-0940
Labeler Name: Antigen Laboratories, Inc.
Product Type: NON-STANDARDIZED ALLERGENIC
FDA Application Number: BLA102223
Marketing Category: BLA
Start Marketing Date: 19861031

Package Information of Treatment Set TS350619

Package NDC: 49288-0940-3
Package Description: 10 mL in 1 VIAL, MULTI-DOSE (49288-0940-3)

NDC Information of Treatment Set TS350619

NDC Code 49288-0940-3
Proprietary Name Treatment Set TS350619
Package Description 10 mL in 1 VIAL, MULTI-DOSE (49288-0940-3)
Product NDC 49288-0940
Product Type Name NON-STANDARDIZED ALLERGENIC
Non Proprietary Name Treatment Set TS350619
Dosage Form Name INJECTION, SOLUTION
Route Name INTRADERMAL; SUBCUTANEOUS
Start Marketing Date 19861031
Marketing Category Name BLA
Labeler Name Antigen Laboratories, Inc.
Substance Name FELIS CATUS HAIR; PHLEUM PRATENSE POLLEN; QUERCUS RUBRA POLLEN
Strength Number 304.04; 10000; .01
Strength Unit [BAU]/mL; [BAU]/mL; g/mL
Pharmaceutical Classes Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Standardized Animal Hair Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Dander [Chemical/Ingredient],Allergens [Chemical/Ingredient],Salivary Proteins and Peptides [Chemical/Ingredient],Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient]

Complete Information of Treatment Set TS350619


General Information